var data={"title":"Clinical use of ginkgo biloba","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Clinical use of ginkgo biloba</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/contributors\" class=\"contributor contributor_credentials\">Robert B Saper, MD, MPH</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/contributors\" class=\"contributor contributor_credentials\">Joann G Elmore, MD, MPH</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/contributors\" class=\"contributor contributor_credentials\">Judith A Melin, MA, MD, FACP</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Oct 17, 2016.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Ginkgo biloba, more commonly known as ginkgo, has been used medicinally for over 1000 years [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/1\" class=\"abstract_t\">1</a>]. The ginkgo tree is the world's oldest living tree species (<a href=\"image.htm?imageKey=PC%2F57799\" class=\"graphic graphic_picture graphicRef57799 \">picture 1</a>).</p><p>Ginkgo was originally utilized by traditional Chinese clinicians for a variety of problems including asthma and digestive disorders [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/1\" class=\"abstract_t\">1</a>]. More recently, ginkgo leaf extract has been utilized for its antioxidant properties, for a number of vascular problems, and for the treatment of memory loss, dementia, and macular degeneration [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/2\" class=\"abstract_t\">2</a>]. Ginkgo represents one of the most studied and commonly used herbal remedies in the world. The National Health Interview Survey found that ginkgo was the ninth most popular natural product in the United States in 2012 [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/3\" class=\"abstract_t\">3</a>]. Over 400 clinical trials have been performed looking at a variety of medicinal properties and clinical uses.</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">MECHANISM OF ACTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>It is thought that there are two main groups of active constituents responsible for ginkgo biloba's medicinal effects: terpene lactones and ginkgo flavone glycosides, which are present in varying concentrations in the leaf of the ginkgo tree [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/4,5\" class=\"abstract_t\">4,5</a>]. Approximately 40 different flavonoids have been isolated, including ginkgetin, bilobetin, and sciadopitysin [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/6\" class=\"abstract_t\">6</a>]. Terpenes isolated include a number of ginkgolides and diterpenes, most importantly the ginkgolides A, B, and C along with bilobalide [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/4\" class=\"abstract_t\">4</a>].</p><p>The bioactive properties of ginkgo biloba extracts are varied. Ginkgo biloba extract appears to alter neurotransmission and provide neuroprotection via a number of mechanisms demonstrated in animal models, including decreased glucose utilization in brain areas mediating somatosensory processing and vigilance [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/7\" class=\"abstract_t\">7</a>]. Furthermore, ginkgo reduces the number of peripheral adrenal benzodiazepine receptors, altering corticosteroid secretion [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/8\" class=\"abstract_t\">8</a>]. Ginkgo biloba extract also has been shown to protect against age-related changes in the mouse hippocampus [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/9\" class=\"abstract_t\">9</a>]. Other studies indicate that ginkgo biloba extract reversibly inhibits monoamine oxidase A and B [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/10\" class=\"abstract_t\">10</a>].</p><p>Other studies examining the mechanism of action include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Animal studies have found that the terpene lactones inhibit the binding of platelet-activating factor (PAF) to its membrane receptor [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/11\" class=\"abstract_t\">11</a>]. Ginkgolides also have a protective effect against PAF-induced bronchoconstriction and airway hyperactivity [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/6\" class=\"abstract_t\">6</a>]. Antagonism of PAF has been studied in animal models, looking at improved myocardial contractility and coronary flow in guinea pig hearts [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/6\" class=\"abstract_t\">6</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Ginkgo biloba extracts demonstrate antioxidant properties in gamma irradiated rabbits, resulting in reduced superoxide release in polymorphonuclear cells [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/12\" class=\"abstract_t\">12</a>]. Flavone glycosides including quercetin, kaempferol, and isorhamnetin are also noted to have antioxidant properties and inhibit platelet aggregation [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/13\" class=\"abstract_t\">13</a>]. These actions are thought to protect brain tissue against hypoxic damage and improve cerebral metabolism [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/4\" class=\"abstract_t\">4</a>]. In particular, the constituents of ginkgo may act as scavengers for free radicals [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/14\" class=\"abstract_t\">14</a>], which are likely mediators of the lipid peroxidation and cell damage observed in Alzheimer disease [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/15,16\" class=\"abstract_t\">15,16</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Ginkgo may increase cholinergic transmission in the brain via inhibition of acetylcholinesterase [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/17\" class=\"abstract_t\">17</a>]; this may have further implications for Alzheimer disease therapy.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The vascular effects of ginkgo are thought to be due to vasodilation secondary to stimulation of the endothelium-derived relaxing factor and prostacyclin release [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/18\" class=\"abstract_t\">18</a>]. Other studies suggest that ginkgo biloba may inhibit nitric oxide, thereby leading to vascular relaxation [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/19,20\" class=\"abstract_t\">19,20</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Ginkgo extracts lower the serum fibrinogen concentration [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/21\" class=\"abstract_t\">21</a>].</p><p/><p class=\"headingAnchor\" id=\"H3\"><span class=\"h1\">CLINICAL TRIALS/INDICATIONS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Numerous clinical trials have been performed using ginkgo for a variety of central nervous system and vascular conditions [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/18\" class=\"abstract_t\">18</a>].</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h2\">Central nervous system disorders</span></p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h3\">Treatment of dementia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Data are mixed on the efficacy of ginkgo biloba extract for the treatment of Alzheimer or vascular dementia [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/22-27\" class=\"abstract_t\">22-27</a>]. (See <a href=\"topic.htm?path=treatment-of-dementia\" class=\"medical medical_review\">&quot;Treatment of dementia&quot;</a>.)</p><p>For example, a randomized double-blind placebo-controlled trial used the standardized extract of ginkgo biloba (EGb) 761 (120 mg per day) in 200 mildly to severely demented patients with Alzheimer disease or vascular dementia [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/26\" class=\"abstract_t\">26</a>]. The ginkgo group demonstrated modest improvement in cognitive performance (as assessed by cognitive rating scales) and social functioning at six months compared with placebo. At 12 months, the ginkgo group had returned to baseline but was still significantly better than the placebo group, which had continued to deteriorate. Twenty-nine percent of the patients treated with ginkgo for at least 26 weeks improved by four or more points on the Alzheimer Disease Assessment Scale-Cognitive subscale (ADAS-Cog) compared with 13 percent in the placebo group. Improvement on the ADAS-Cog of four points is equivalent to a six-month delay in disease progression [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/22\" class=\"abstract_t\">22</a>].</p><p>A 2009 systematic review included 36 trials of ginkgo for cognitive impairment and dementia. Results from more recent, larger, higher-quality trials were inconsistent in terms of an effect on cognition, function, mood, and caregiver stress. Three of the four most recent trials did not find an effect of ginkgo over placebo. Adverse events for ginkgo and placebo were similar. The review concluded that the evidence for clinically significant benefit with ginkgo for cognitive impairment or dementia is inconsistent and unconvincing [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/28\" class=\"abstract_t\">28</a>].</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h3\">Prevention of dementia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Ginkgo biloba appears to be ineffective in preventing progression to dementia, both in older adults with normal cognition and in those with mild cognitive impairment (MCI). The Ginkgo Evaluation of Memory (GEM) study was a large, multicenter trial that randomly assigned 3069 adults ages 75 and older (approximately 15 percent with MCI at baseline) to ginkgo biloba extract 120 mg twice daily or placebo [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/29\" class=\"abstract_t\">29</a>]. Ginkgo biloba did not reduce the risk of dementia in the cohort (hazard ratio [HR] 1.12, 95% CI 0.94-1.33) or in the subset of patients with MCI at baseline (HR 1.13, CI 0.85-1.50).</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h3\">Age-related memory impairment</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Most studies do not show benefit of ginkgo in improving age-related memory loss in cognitively intact adults [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/30-33\" class=\"abstract_t\">30-33</a>].</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In the GEM Study (see <a href=\"#H6\" class=\"local\">'Prevention of dementia'</a> above), there was no difference in cognitive decline as measured by memory, attention, language, visuospatial abilities, or executive functions based on neuropsychological testing, including the Modified Mini-Mental State Examination and the Alzheimer Disease Assessment Scale.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A double-blind trial that investigated the use of ginkgo biloba extract for memory enhancement in cognitively intact older adults did not show a beneficial effect [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/31\" class=\"abstract_t\">31</a>]. This study randomly assigned 230 community dwelling men and women over the age of 60 with Mini-Mental State Examination scores greater than 26 to receive ginkgo biloba (Ginkoba, Boehringer Ingelheim Pharmaceuticals) 40 mg three times daily or matching placebo for six weeks. There was no improvement in memory with ginkgo treatment as measured by standard neuropsychological tests, self-reported memory function, or global rating by spouses, friends, and relatives. One potential weakness of this study is that the investigators did not chemically verify the ginkgo content of the preparation used.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In a placebo-controlled trial of 214 patients with memory impairment from a variety of causes, participants received EGb 761 (at a high dose of 240 mg or a low dose of 160 mg) or placebo for 24 weeks [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/32\" class=\"abstract_t\">32</a>]. No improvement in memory function with ginkgo compared with placebo was found.</p><p/><p>Other studies have found contradictory results [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/23,34-38\" class=\"abstract_t\">23,34-38</a>]. However, most of these studies were small, and the beneficial effects did not cover a broad range of findings nor were they consistent. One randomized trial in 118 people over age 84 found a non-statistically significant trend toward less cognitive decline with ginkgo, but also an increased incidence of strokes [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/39\" class=\"abstract_t\">39</a>].</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h2\">Other disorders</span></p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h3\">Psychiatric disorders</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Ginkgo biloba has been studied as a treatment for depression and other psychiatric disorders:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>One study of 40 older adult patients with depression compared treatment with ginkgo biloba extract with placebo [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/40\" class=\"abstract_t\">40</a>]. The average total score on the Hamilton Depression Scale after four weeks fell significantly in those treated with ginkgo biloba extract compared with placebo.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A small double-blind study of 27 patients found that ginkgo was not effective in preventing seasonal affective disorder [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/41\" class=\"abstract_t\">41</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In a randomized trial of 157 patients with schizophrenia and tardive dyskinesia, ginkgo biloba was effective in reducing tardive dyskinesia [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/42\" class=\"abstract_t\">42</a>]. </p><p/><p class=\"headingAnchor\" id=\"H11\"><span class=\"h3\">Sexual dysfunction</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Studies have examined the effects of ginkgo biloba on sexual function:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A small study of men with erectile dysfunction secondary to decreased blood flow found that those treated with ginkgo biloba extract had an improvement in penile blood flow in six weeks [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/43\" class=\"abstract_t\">43</a>]. After six months, 50 percent of patients treated were noted to regain potency.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In an open trial, 37 male and female patients with selective serotonin reuptake inhibitor (SSRI)-associated sexual dysfunction were treated with ginkgo biloba extract [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/44\" class=\"abstract_t\">44</a>]. Significant improvement was noted after four weeks in 86 percent of patients. A small randomized trial failed to show similar benefits [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/45\" class=\"abstract_t\">45</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A proprietary combination product containing ginkgo biloba improved libido in a randomized trial of 108 women ages 22 to 73 [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/46\" class=\"abstract_t\">46</a>].</p><p/><p class=\"headingAnchor\" id=\"H12\"><span class=\"h3\">Vertigo</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In one double-blind, randomized, placebo-controlled study of patients with vertigo of recent onset and undetermined origin, ginkgo biloba extract was associated with a significant reduction in vertigo symptoms compared with placebo (47 versus 18 percent, respectively) [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/47\" class=\"abstract_t\">47</a>].</p><p class=\"headingAnchor\" id=\"H13\"><span class=\"h3\">Vitiligo</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A feasibility trial of 12 patients [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/48\" class=\"abstract_t\">48</a>] and a randomized trial in 47 patients found ginkgo biloba extract (40 mg three times daily) to be a promising treatment of vitiligo [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/49\" class=\"abstract_t\">49</a>]. (See <a href=\"topic.htm?path=vitiligo-management-and-prognosis#H3524344554\" class=\"medical medical_review\">&quot;Vitiligo: Management and prognosis&quot;, section on 'Complementary and alternative therapies'</a>.)</p><p class=\"headingAnchor\" id=\"H14\"><span class=\"h3\">Macular degeneration</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A 2013 systematic review identified two small six-month trials, one comparing ginkgo biloba extract with placebo (n = 20) and the other comparing two different doses of the extract (n = 99); the results were not pooled [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/50\" class=\"abstract_t\">50</a>]. There was some suggestion of benefit in these trials. Further larger and longer trials need to be conducted to assess ginkgo&rsquo;s efficacy for macular degeneration. (See <a href=\"topic.htm?path=age-related-macular-degeneration-clinical-presentation-etiology-and-diagnosis\" class=\"medical medical_review\">&quot;Age-related macular degeneration: Clinical presentation, etiology, and diagnosis&quot;</a>.)</p><p>In addition, ginkgo biloba extract may protect the retina from free radical damage in patients with diabetic retinopathy [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/51\" class=\"abstract_t\">51</a>] and may improve visual field test results in normal-tension glaucoma [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/52\" class=\"abstract_t\">52</a>].</p><p class=\"headingAnchor\" id=\"H83976928\"><span class=\"h3\">Peripheral vascular disease</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>It is unclear if ginkgo biloba extract is effective for claudication in patients with peripheral vascular disease. This is discussed in detail elsewhere. (See <a href=\"topic.htm?path=management-of-claudication#H200381319\" class=\"medical medical_review\">&quot;Management of claudication&quot;, section on 'Benefit not firmly established'</a>.)</p><p class=\"headingAnchor\" id=\"H15\"><span class=\"h3\">Altitude sickness</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In 44 Himalayan climbers, 22 subjects treated with ginkgo biloba extract developed significantly fewer cerebral and respiratory symptoms of mountain sickness than climbers taking placebo [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/53\" class=\"abstract_t\">53</a>]. By contrast, a large, randomized trial in 614 climbers found no benefit for prevention of acute mountain sickness with ginkgo compared with placebo or for the combination of ginkgo and <a href=\"topic.htm?path=acetazolamide-drug-information\" class=\"drug drug_general\">acetazolamide</a> compared with acetazolamide alone [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/54\" class=\"abstract_t\">54</a>]. A subsequent smaller study also found benefit with acetazolamide but not with ginkgo [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/55\" class=\"abstract_t\">55</a>].</p><p class=\"headingAnchor\" id=\"H16\"><span class=\"h3\">Tinnitus</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Despite traditional use of ginkgo for tinnitus, well-designed studies do not support efficacy for this disorder. A meta-analysis of four trials of 1543 patients taking ginkgo did not show a reduction in levels of tinnitus [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/56\" class=\"abstract_t\">56</a>]. The treatment of tinnitus is discussed separately. (See <a href=\"topic.htm?path=treatment-of-tinnitus\" class=\"medical medical_review\">&quot;Treatment of tinnitus&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H17\"><span class=\"h1\">SAFETY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Ginkgo biloba leaf extract generally appears to be safe and well-tolerated when used in standard doses in clinical trials lasting up to one year [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/6\" class=\"abstract_t\">6</a>]. In one study, no significant adverse reactions were reported in patients taking as much as 600 mg of leaf extracts in single doses [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/11\" class=\"abstract_t\">11</a>]. Mild adverse effects include gastrointestinal upset and headaches [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/11\" class=\"abstract_t\">11</a>]. Several cases of bleeding associated with ginkgo extracts have been reported [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/57\" class=\"abstract_t\">57</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Combined use of <a href=\"topic.htm?path=aspirin-drug-information\" class=\"drug drug_general\">aspirin</a> and ginkgo resulted in spontaneous bleeding into the anterior chamber of the eye [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/58\" class=\"abstract_t\">58</a>]</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Spontaneous bilateral subdural hematoma with a prolonged bleeding time [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/59\" class=\"abstract_t\">59</a>]</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Chronic left frontal subdural hematoma [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/60\" class=\"abstract_t\">60</a>]</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Subarachnoid hemorrhage [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/61,62\" class=\"abstract_t\">61,62</a>]</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Bilateral hematoma after rhytidoplasty and blepharoplasty [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/63\" class=\"abstract_t\">63</a>]</p><p/><p>A meta-analysis of 18 randomized trials of Ginkgo biloba (n = 1985) with a variety of conditions was conducted to assess any effect of Ginkgo on bleeding parameters; there was no significant effect of Ginkgo on platelet aggregation, prothrombin time, or activated partial thromboplastin time [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/64\" class=\"abstract_t\">64</a>].</p><p>Patients should be advised that contact with or ingestion of ginkgo's nonleaf parts (eg, seed, fruit, or nut) can result in serious allergic reactions including blisters, erythema, and itching [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/65-67\" class=\"abstract_t\">65-67</a>].</p><p class=\"headingAnchor\" id=\"H18\"><span class=\"h1\">INTERACTIONS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The risk of spontaneous bleeding may be increased when ginkgo biloba extract is combined with nonsteroidal antiinflammatory drugs (NSAIDs) and anticoagulants such as heparin or <a href=\"topic.htm?path=warfarin-drug-information\" class=\"drug drug_general\">warfarin</a> [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/68\" class=\"abstract_t\">68</a>]. Concomitant use of ginkgo with these agents should be avoided. Episodes of serious bleeding from the use of ginkgo and low-dose (81 <span class=\"nowrap\">mg/day)</span> daily <a href=\"topic.htm?path=aspirin-drug-information\" class=\"drug drug_general\">aspirin</a> prophylaxis have not been reported. Although this combination is likely safe, caution should be exercised.</p><p>Ginkgo 90 <span class=\"nowrap\">mg/day</span> did not show any adverse effects on the pharmacokinetics of <a href=\"topic.htm?path=donepezil-drug-information\" class=\"drug drug_general\">donepezil</a> 5 <span class=\"nowrap\">mg/day</span> when administered together [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/69\" class=\"abstract_t\">69</a>]. Potential adverse or synergistic interactions with other medications used in treating dementia are unknown.</p><p>Caution should be exercised when ginkgo is combined with other herbs known to increase bleeding (eg, garlic, ginseng, ginger).</p><p>The major components of ginkgo biloba preparations (terpenes, flavonol glycosides) do not significantly inhibit human cytochrome P450 isoforms in vitro [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/70\" class=\"abstract_t\">70</a>]. However, other components of ginkgo (flavonol aglycones, the biflavonoid amentoflavone) do inhibit CYP1A2 and CYP3A4. The clinical importance of these potential interactions is uncertain.</p><p>Ginkgo biloba extract may theoretically potentiate the effects of monoamine oxidase inhibitors (MAOIs) at high doses due to the inhibition of the uptake of serotonin and dopamine [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/71,72\" class=\"abstract_t\">71,72</a>]. One study showed reversible inhibition of monoamine oxidase in rats fed ginkgo extract [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/71\" class=\"abstract_t\">71</a>]. This has led some to caution against the use of ginkgo biloba extract in patients taking other antidepressants due to the potential risk of precipitating serotonin syndrome (agitation, hyperthermia, diaphoresis, tachycardia, and neuromuscular disturbances including rigidity) [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/7\" class=\"abstract_t\">7</a>] (see <a href=\"topic.htm?path=drug-fever#H757595\" class=\"medical medical_review\">&quot;Drug fever&quot;, section on 'Serotonin syndrome'</a>). Patients should be advised of the potential for these interactions, although the true risk is unknown [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/68\" class=\"abstract_t\">68</a>].</p><p class=\"headingAnchor\" id=\"H19\"><span class=\"h1\">DOSE</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The majority of the studies looking at ginkgo extract utilized the standardized extract of ginkgo biloba (EGb) 761. EGb 761 is standardized to contain 24% flavonoid glycosides and 6% terpenoids [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/73\" class=\"abstract_t\">73</a>]. Typical dosages of EGb 761 used in studies and recommended by manufacturers are 40 mg three times per day, or 80 mg twice daily.</p><p class=\"headingAnchor\" id=\"H20\"><span class=\"h1\">BRAND</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Although new Good Manufacturing Practices for the dietary supplement industry established by the US Food and Drug Administration (FDA) were phased in from 2008 to 2010 [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/74\" class=\"abstract_t\">74</a>], quality control of dietary supplements is still variable. Patients should use brands which have passed specified quality criteria by independent commercial laboratories (<a href=\"image.htm?imageKey=PC%2F78899\" class=\"graphic graphic_table graphicRef78899 \">table 1</a>).</p><p class=\"headingAnchor\" id=\"H21\"><span class=\"h1\">CONTRAINDICATIONS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Caution should be exercised with ginkgo in patients with bleeding disorders or those who take anticoagulant drugs.</p><p>Although animal data do not show mutagenic or teratogenic effects [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/1\" class=\"abstract_t\">1</a>], the lack of data regarding use in pregnancy and lactation warrants that it not be used in this population [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/1\" class=\"abstract_t\">1</a>].</p><p>Little data exist about the risk of perioperative complications due to ginkgo use. Based upon a literature review, some experts recommended that because of the potential bleeding risk associated with ginkgo it should be discontinued at least 36 hours prior to a planned surgical procedure [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/75\" class=\"abstract_t\">75</a>].</p><p>Isolated reports of seizure associated with ginkgo use have been published [<a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/76-78\" class=\"abstract_t\">76-78</a>]. Whether ginkgo lowers seizure threshold is uncertain. Use of ginkgo in patients with seizure disorders should therefore be done with caution.</p><p class=\"headingAnchor\" id=\"H22\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Ginkgo biloba, more commonly known as ginkgo, has been used medicinally for over 1000 years. The ginkgo tree is the world's oldest living tree species (<a href=\"image.htm?imageKey=PC%2F57799\" class=\"graphic graphic_picture graphicRef57799 \">picture 1</a>). Ginkgo was originally utilized by traditional Chinese clinicians for a variety of problems including asthma and digestive disorders. More recently, ginkgo leaf extract has been utilized for its antioxidant properties, for a number of vascular problems, and for the treatment of memory loss, dementia, and macular degeneration.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>We suggest not treating dementia or age-related memory impairment with ginkgo biloba (<a href=\"grade.htm?i=5\" class=\"grade\">Grade 2B</a>). (See <a href=\"#H5\" class=\"local\">'Treatment of dementia'</a> above and <a href=\"#H7\" class=\"local\">'Age-related memory impairment'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>We recommend not administering ginkgo biloba for prevention of dementia (<a href=\"grade.htm?i=1\" class=\"grade\">Grade 1A</a>). (See <a href=\"#H6\" class=\"local\">'Prevention of dementia'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Ginkgo is generally well-tolerated, although case reports of bleeding problems suggest that it should not be used perioperatively or in patients with known bleeding disorders. It should be avoided or used with caution in patients receiving anticoagulants. (See <a href=\"#H17\" class=\"local\">'Safety'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Variability in the quality and purity of available products limits the ability of the clinician to provide sound advice to the patient. If patients do choose to take ginkgo biloba, a product should be chosen that meets specific quality criteria (<a href=\"image.htm?imageKey=PC%2F78899\" class=\"graphic graphic_table graphicRef78899 \">table 1</a>). (See <a href=\"#H20\" class=\"local\">'Brand'</a> above.) </p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li class=\"breakAll\">Lawrence Review of Natural Products. Ginkgo Biloba. Facts and Comparisons, St. Louis 1998.</li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/2\" class=\"nounderline abstract_t\">Lin JH. Evaluating the alternatives. JAMA 1998; 279:706.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/3\" class=\"nounderline abstract_t\">Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report 2008; :1.</a></li><li class=\"breakAll\">Brown D, Gaby A, Reichert R, et al. Clinical Applications of Natural Medicine. In: Dementia and Age-Related Cognitive Decline, Natural Product Research Consultants, Seattle 1997. p.10.</li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/5\" class=\"nounderline abstract_t\">Ude C, Schubert-Zsilavecz M, Wurglics M. Ginkgo biloba extracts: a review of the pharmacokinetics of the active ingredients. Clin Pharmacokinet 2013; 52:727.</a></li><li class=\"breakAll\">Newall CA, Anderson LA, Phillipson JD. Ginkgo Biloba. In: Herbal Medicines: A Guide for Health-Care Professionals, Pharmaceutical Press, London 1996. p.138.</li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/7\" class=\"nounderline abstract_t\">Ginkgo biloba. Altern Med Rev 1998; 3:54.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/8\" class=\"nounderline abstract_t\">Marcilhac A, Dakine N, Bourhim N, et al. Effect of chronic administration of Ginkgo biloba extract or Ginkgolide on the hypothalamic-pituitary-adrenal axis in the rat. Life Sci 1998; 62:2329.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/9\" class=\"nounderline abstract_t\">Barkats M, Venault P, Christen Y, Cohen-Salmon C. Effect of long-term treatment with EGb 761 on age-dependent structural changes in the hippocampi of three inbred mouse strains. Life Sci 1995; 56:213.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/10\" class=\"nounderline abstract_t\">White HL, Scates PW, Cooper BR. Extracts of Ginkgo biloba leaves inhibit monoamine oxidase. Life Sci 1996; 58:1315.</a></li><li class=\"breakAll\">Pizzorno JE, Murray MT. A textbook of natural medicine, John Bastyr College Publications, Seattle 1985.</li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/12\" class=\"nounderline abstract_t\">Wada K, Ishigaki S, Ueda K, et al. Studies on the constitution of edible and medicinal plants. I. Isolation and identification of 4-O-methylpyridoxine, toxic principle from the seed of Ginkgo biloba L. Chem Pharm Bull (Tokyo) 1988; 36:1779.</a></li><li class=\"breakAll\">Drieu K. Preparation and definition of Ginkgo biloba extract. In: Rokan (Ginkgo biloba): Recent Results in Pharmacology and Clinic, Funfgeld EW (Ed), Springer-Verlag, Berlin 1988. p.32.</li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/14\" class=\"nounderline abstract_t\">Oyama Y, Fuchs PA, Katayama N, Noda K. Myricetin and quercetin, the flavonoid constituents of Ginkgo biloba extract, greatly reduce oxidative metabolism in both resting and Ca(2+)-loaded brain neurons. Brain Res 1994; 635:125.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/15\" class=\"nounderline abstract_t\">Behl C, Davis JB, Lesley R, Schubert D. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 1994; 77:817.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/16\" class=\"nounderline abstract_t\">Benzi G, Moretti A. Are reactive oxygen species involved in Alzheimer's disease? Neurobiol Aging 1995; 16:661.</a></li><li class=\"breakAll\">Ginkgo Biloba Extract (Egb761) Pharmacological Act and Clinical Application, DeFeudis FV (Ed), Elsevier, Paris 1991.</li><li class=\"breakAll\">Murray M. The Healing Power of Herbs, 2nd ed, Prima Publishing, Rocklin, CA 1995. p.147.</li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/19\" class=\"nounderline abstract_t\">Chen X, Salwinski S, Lee TJ. Extracts of Ginkgo biloba and ginsenosides exert cerebral vasorelaxation via a nitric oxide pathway. Clin Exp Pharmacol Physiol 1997; 24:958.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/20\" class=\"nounderline abstract_t\">Kobuchi H, Droy-Lefaix MT, Christen Y, Packer L. Ginkgo biloba extract (EGb 761): inhibitory effect on nitric oxide production in the macrophage cell line RAW 264.7. Biochem Pharmacol 1997; 53:897.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/21\" class=\"nounderline abstract_t\">Anadere I, Witte S. Hemorrheological findings in patients with completed stroke and the influence of GBE. Clin Hemorrheol 1985; 4:411.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/22\" class=\"nounderline abstract_t\">Stern RG, Mohs RC, Davidson M, et al. A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration. Am J Psychiatry 1994; 151:390.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/23\" class=\"nounderline abstract_t\">Semlitsch HV, Anderer P, Saletu B, et al. Cognitive psychophysiology in nootropic drug research: effects of Ginkgo biloba on event-related potentials (P300) in age-associated memory impairment. Pharmacopsychiatry 1995; 28:134.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/24\" class=\"nounderline abstract_t\">Kanowski S, Herrmann WM, Stephan K, et al. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia. Pharmacopsychiatry 1996; 29:47.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/25\" class=\"nounderline abstract_t\">Rai GS, Shovlin C, Wesnes KA. A double-blind, placebo controlled study of Ginkgo biloba extract ('tanakan') in elderly outpatients with mild to moderate memory impairment. Curr Med Res Opin 1991; 12:350.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/26\" class=\"nounderline abstract_t\">Le Bars PL, Katz MM, Berman N, et al. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. JAMA 1997; 278:1327.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/27\" class=\"nounderline abstract_t\">Schneider LS, DeKosky ST, Farlow MR, et al. A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer's type. Curr Alzheimer Res 2005; 2:541.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/28\" class=\"nounderline abstract_t\">Birks J, Grimley Evans J. Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst Rev 2009; :CD003120.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/29\" class=\"nounderline abstract_t\">DeKosky ST, Williamson JD, Fitzpatrick AL, et al. Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA 2008; 300:2253.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/30\" class=\"nounderline abstract_t\">Snitz BE, O'Meara ES, Carlson MC, et al. Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial. JAMA 2009; 302:2663.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/31\" class=\"nounderline abstract_t\">Solomon PR, Adams F, Silver A, et al. Ginkgo for memory enhancement: a randomized controlled trial. JAMA 2002; 288:835.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/32\" class=\"nounderline abstract_t\">van Dongen MC, van Rossum E, Kessels AG, et al. The efficacy of ginkgo for elderly people with dementia and age-associated memory impairment: new results of a randomized clinical trial. J Am Geriatr Soc 2000; 48:1183.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/33\" class=\"nounderline abstract_t\">Carlson JJ, Farquhar JW, DiNucci E, et al. Safety and efficacy of a ginkgo biloba-containing dietary supplement on cognitive function, quality of life, and platelet function in healthy, cognitively intact older adults. J Am Diet Assoc 2007; 107:422.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/34\" class=\"nounderline abstract_t\">Kleijnen J, Knipschild P. Ginkgo biloba. Lancet 1992; 340:1136.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/35\" class=\"nounderline abstract_t\">Schmidt U, Rabinovici K, Lande S. Einfluss eines Ginkgo biloba Specialextraktes auf doe befomdlickeit bei zerebraler Onsufficizienz. Muench Med Wochenschr 1991; 133(Suppl 1):S15.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/36\" class=\"nounderline abstract_t\">Bruchert E, Heinrich SE, Ruf-Kohler P. Wirksamkeit von LI 1370 bei alteren Patienten mit Himleistungsschwache. Multizentrische doppelblindstudie des fachverbandes Deutsher Allegemeinaezte. Muench Med Wochenschr 1991; 133(Suppl 1):S9.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/37\" class=\"nounderline abstract_t\">Wesnes K, et al. A double-blind placebo-controlled trial of Tanakan in the treatment of idiopathic cognitive impairment in the elderly. Hum Psychopharmacol 1987; 2:159.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/38\" class=\"nounderline abstract_t\">Hopfenm&uuml;ller W. [Evidence for a therapeutic effect of Ginkgo biloba special extract. Meta-analysis of 11 clinical studies in patients with cerebrovascular insufficiency in old age]. Arzneimittelforschung 1994; 44:1005.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/39\" class=\"nounderline abstract_t\">Dodge HH, Zitzelberger T, Oken BS, et al. A randomized placebo-controlled trial of Ginkgo biloba for the prevention of cognitive decline. Neurology 2008; 70:1809.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/40\" class=\"nounderline abstract_t\">Schubert H, Halama P. Depressive episode primarily unresponsive to therapy in elderly patients: Efficacy of Ginkgo biloba (EGb 761) in combination with antidepressants. Geriatr Forsch 1993; 3:45.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/41\" class=\"nounderline abstract_t\">Lingaerde O, F&oslash;reland AR, Magnusson A. Can winter depression be prevented by Ginkgo biloba extract? A placebo-controlled trial. Acta Psychiatr Scand 1999; 100:62.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/42\" class=\"nounderline abstract_t\">Zhang WF, Tan YL, Zhang XY, et al. Extract of Ginkgo biloba treatment for tardive dyskinesia in schizophrenia: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 2011; 72:615.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/43\" class=\"nounderline abstract_t\">Sikora R, Sohn M, Deutz FJ, et al. Ginkgo biloba extract in the therapy of erectile dysfunction. J Urol 1989; 141:188.</a></li><li class=\"breakAll\">Cohen, AJ, Bartlik, BD. Ginkgo biloba for drug-induced sexual dysfunction. Presented at the American Psychiatric Association Annual Meeting, San Diego 1997.</li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/45\" class=\"nounderline abstract_t\">Wheatley D. Triple-blind, placebo-controlled trial of Ginkgo biloba in sexual dysfunction due to antidepressant drugs. Hum Psychopharmacol 2004; 19:545.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/46\" class=\"nounderline abstract_t\">Ito TY, Polan ML, Whipple B, Trant AS. The enhancement of female sexual function with ArginMax, a nutritional supplement, among women differing in menopausal status. J Sex Marital Ther 2006; 32:369.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/47\" class=\"nounderline abstract_t\">Haguenauer JP, Cantenot F, Koskas H, Pierart H. [Treatment of equilibrium disorders with Ginkgo biloba extract. A multicenter double-blind drug vs. placebo study]. Presse Med 1986; 15:1569.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/48\" class=\"nounderline abstract_t\">Szczurko O, Shear N, Taddio A, Boon H. Ginkgo biloba for the treatment of vitilgo vulgaris: an open label pilot clinical trial. BMC Complement Altern Med 2011; 11:21.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/49\" class=\"nounderline abstract_t\">Parsad D, Pandhi R, Juneja A. Effectiveness of oral Ginkgo biloba in treating limited, slowly spreading vitiligo. Clin Exp Dermatol 2003; 28:285.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/50\" class=\"nounderline abstract_t\">Evans JR. Ginkgo biloba extract for age-related macular degeneration. Cochrane Database Syst Rev 2013; :CD001775.</a></li><li class=\"breakAll\">Ginkgo Biloba Extract (Egb 761): Pharmacological Activities and Clinical Applications, DeFeudis FV (Ed), Elsevier, Paris  p.1991.</li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/52\" class=\"nounderline abstract_t\">Quaranta L, Bettelli S, Uva MG, et al. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma. Ophthalmology 2003; 110:359.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/53\" class=\"nounderline abstract_t\">Roncin JP, Schwartz F, D'Arbigny P. EGb 761 in control of acute mountain sickness and vascular reactivity to cold exposure. Aviat Space Environ Med 1996; 67:445.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/54\" class=\"nounderline abstract_t\">Gertsch JH, Basnyat B, Johnson EW, et al. Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT). BMJ 2004; 328:797.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/55\" class=\"nounderline abstract_t\">Chow T, Browne V, Heileson HL, et al. Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trial. Arch Intern Med 2005; 165:296.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/56\" class=\"nounderline abstract_t\">Hilton MP, Zimmermann EF, Hunt WT. Ginkgo biloba for tinnitus. Cochrane Database Syst Rev 2013; :CD003852.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/57\" class=\"nounderline abstract_t\">Bent S, Goldberg H, Padula A, Avins AL. Spontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature: a case report and systematic review of the literature. J Gen Intern Med 2005; 20:657.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/58\" class=\"nounderline abstract_t\">Rosenblatt M, Mindel J. Spontaneous hyphema associated with ingestion of Ginkgo biloba extract. N Engl J Med 1997; 336:1108.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/59\" class=\"nounderline abstract_t\">Rowin J, Lewis SL. Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion. Neurology 1996; 46:1775.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/60\" class=\"nounderline abstract_t\">Gilbert GJ. Ginkgo biloba. Neurology 1997; 48:1137.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/61\" class=\"nounderline abstract_t\">Vale S. Subarachnoid haemorrhage associated with Ginkgo biloba. Lancet 1998; 352:36.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/62\" class=\"nounderline abstract_t\">Pedroso JL, Henriques Aquino CC, Esc&oacute;rcio Bezerra ML, et al. Ginkgo biloba and cerebral bleeding: a case report and critical review. Neurologist 2011; 17:89.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/63\" class=\"nounderline abstract_t\">Destro MW, Speranzini MB, Cavalheiro Filho C, et al. Bilateral haematoma after rhytidoplasty and blepharoplasty following chronic use of Ginkgo biloba. Br J Plast Surg 2005; 58:100.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/64\" class=\"nounderline abstract_t\">Kellermann AJ, Kloft C. Is there a risk of bleeding associated with standardized Ginkgo biloba extract therapy? A systematic review and meta-analysis. Pharmacotherapy 2011; 31:490.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/65\" class=\"nounderline abstract_t\">Siegers CP. Cytotoxicity of alkylphenols from Ginkgo biloba. Phytomedicine 1999; 6:281.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/66\" class=\"nounderline abstract_t\">Pennisi RS. Acute generalised exanthematous pustulosis induced by the herbal remedy Ginkgo biloba. Med J Aust 2006; 184:583.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/67\" class=\"nounderline abstract_t\">Hasegawa S, Oda Y, Ichiyama T, et al. Ginkgo nut intoxication in a 2-year-old male. Pediatr Neurol 2006; 35:275.</a></li><li class=\"breakAll\">Herb Contraindications and Drug Interactions, 2nd ed, Brinker F (Ed), Eclectic Medical Publications, Sandy, OR 1998.</li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/69\" class=\"nounderline abstract_t\">Yasui-Furukori N, Furukori H, Kaneda A, et al. The effects of Ginkgo biloba extracts on the pharmacokinetics and pharmacodynamics of donepezil. J Clin Pharmacol 2004; 44:538.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/70\" class=\"nounderline abstract_t\">von Moltke LL, Weemhoff JL, Bedir E, et al. Inhibition of human cytochromes P450 by components of Ginkgo biloba. J Pharm Pharmacol 2004; 56:1039.</a></li><li class=\"breakAll\">American Herbal Products Association's Botanical Safety Handbook, McGuffin M, Hobbs C, Upton R, et al (Eds), CRC Press, Boca Raton, FL 1997.</li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/72\" class=\"nounderline abstract_t\">Ramassamy C, Christen Y, Clostre F, Costentin J. The Ginkgo biloba extract, EGb761, increases synaptosomal uptake of 5-hydroxytryptamine: in-vitro and ex-vivo studies. J Pharm Pharmacol 1992; 44:943.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/73\" class=\"nounderline abstract_t\">O'Hara M, Kiefer D, Farrell K, Kemper K. A review of 12 commonly used medicinal herbs. Arch Fam Med 1998; 7:523.</a></li><li class=\"breakAll\">www.fda.gov/bbs/topcs/NEWS/2007/NEW01657.html (Accessed on October 09, 2007).</li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/75\" class=\"nounderline abstract_t\">Ang-Lee MK, Moss J, Yuan CS. Herbal medicines and perioperative care. JAMA 2001; 286:208.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/76\" class=\"nounderline abstract_t\">Gregory PJ. Seizure associated with Ginkgo biloba? Ann Intern Med 2001; 134:344.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/77\" class=\"nounderline abstract_t\">Granger AS. Ginkgo biloba precipitating epileptic seizures. Age Ageing 2001; 30:523.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-ginkgo-biloba/abstract/78\" class=\"nounderline abstract_t\">Kupiec T, Raj V. Fatal seizures due to potential herb-drug interactions with Ginkgo biloba. J Anal Toxicol 2005; 29:755.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 1387 Version 24.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H22\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">MECHANISM OF ACTION</a></li><li><a href=\"#H3\" id=\"outline-link-H3\">CLINICAL TRIALS/INDICATIONS</a><ul><li><a href=\"#H4\" id=\"outline-link-H4\">Central nervous system disorders</a><ul><li><a href=\"#H5\" id=\"outline-link-H5\">- Treatment of dementia</a></li><li><a href=\"#H6\" id=\"outline-link-H6\">- Prevention of dementia</a></li><li><a href=\"#H7\" id=\"outline-link-H7\">- Age-related memory impairment</a></li></ul></li><li><a href=\"#H8\" id=\"outline-link-H8\">Other disorders</a><ul><li><a href=\"#H10\" id=\"outline-link-H10\">- Psychiatric disorders</a></li><li><a href=\"#H11\" id=\"outline-link-H11\">- Sexual dysfunction</a></li><li><a href=\"#H12\" id=\"outline-link-H12\">- Vertigo</a></li><li><a href=\"#H13\" id=\"outline-link-H13\">- Vitiligo</a></li><li><a href=\"#H14\" id=\"outline-link-H14\">- Macular degeneration</a></li><li><a href=\"#H83976928\" id=\"outline-link-H83976928\">- Peripheral vascular disease</a></li><li><a href=\"#H15\" id=\"outline-link-H15\">- Altitude sickness</a></li><li><a href=\"#H16\" id=\"outline-link-H16\">- Tinnitus</a></li></ul></li></ul></li><li><a href=\"#H17\" id=\"outline-link-H17\">SAFETY</a></li><li><a href=\"#H18\" id=\"outline-link-H18\">INTERACTIONS</a></li><li><a href=\"#H19\" id=\"outline-link-H19\">DOSE</a></li><li><a href=\"#H20\" id=\"outline-link-H20\">BRAND</a></li><li><a href=\"#H21\" id=\"outline-link-H21\">CONTRAINDICATIONS</a></li><li><a href=\"#H22\" id=\"outline-link-H22\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"PC/1387|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=PC/57799\" class=\"graphic graphic_picture\">- Ginkgo biloba</a></li></ul></li><li><div id=\"PC/1387|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=PC/78899\" class=\"graphic graphic_table\">- Ginkgo quality criteria</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=age-related-macular-degeneration-clinical-presentation-etiology-and-diagnosis\" class=\"medical medical_review\">Age-related macular degeneration: Clinical presentation, etiology, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=drug-fever\" class=\"medical medical_review\">Drug fever</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-of-claudication\" class=\"medical medical_review\">Management of claudication</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-dementia\" class=\"medical medical_review\">Treatment of dementia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-tinnitus\" class=\"medical medical_review\">Treatment of tinnitus</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=vitiligo-management-and-prognosis\" class=\"medical medical_review\">Vitiligo: Management and prognosis</a></li></ul></div></div>","javascript":null}